Two Brazilian pharmaceutical companies recently suffered a disruptive cyberattack. These companies, Nazária and Drogarias Globo, belong to the Jorge Batista group. They released statements this week confirming the security incident. Both organizations identified significant instabilities within their computer systems. A hostile cyber agent reportedly caused these widespread operational disruptions. The affected Brazilian companies have since reinforced their existing security protocols. They are now diligently working to normalize all their affected services. Customers and partners were informed about the incident’s impact on business.
The companies’ notes provided few details about the cyberattack’s specific nature.
It remains unclear if any sensitive internal data was actually compromised. Whether the two incidents share the same origin is also currently unknown. However, sources of the system instability were identified very quickly by teams. This prompt identification led them to reinforce all crucial cybersecurity measures. Their information security team is dedicated to the full resumption of all activities. Nazária’s technical team acted with the highest priority to resolve the issue. They focused on containing the problem and protecting valuable company data. Full restoration of all services is their key recovery objective now.
Drogarias Globo’s statement indicated the Jorge Batista Group was also a victim.
Despite this, the parent Jorge Batista Group itself has not officially commented yet. The publication Security Report has contacted the Jorge Batista Group directly. They are seeking more details about the cyberattack’s full extent and impact. This article will be updated with new information if the Brazilian group responds. The group’s silence highlights potential communication challenges during such critical security incidents. Clear communication is vital for maintaining trust with stakeholders after an attack.
Brazil’s pharmaceutical sector has unfortunately faced other cyber incidents quite recently. A notable previous attack affected the Institute of Nuclear Research, known as IPEN. The National Nuclear Energy Commission (CNEN) officially confirmed this separate hacking incident. That hacker attack on IPEN forced an immediate stop to essential production processes. Consequently, the supply of several radiopharmaceuticals produced by IPEN was completely halted. These critical medical products were only manufactured again a full week later. This earlier event also shows existing vulnerabilities across Brazil’s important pharmaceutical industry. Protecting such vital infrastructure requires continuous cybersecurity vigilance and robust defenses.
Reference:
